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Abstract
 Research in chlamydial genetics is challenging because of itsBackground:
obligate intracellular developmental cycle.  systems exist that allowIn vivo 
studies of different aspects of basic biology of chlamydiae, the murine 
 model is one of great importance and thus an essentialChlamydia muridarum
research tool.   carries a plasmid that has a role in virulence.  OurC. muridarum
aim was to compare and contrast the  plasmid-free phenotypeC. muridarum 
with that of a chromosomally isogenic plasmid-bearing strain, through the
inclusion phase of the developmental cycle.
 We measured infectivity for plasmid bearing and plasmid-cured Methods: C.
 by inclusion forming assays in McCoy cells and in parallel bacterialmuridarum
chromosome replication by quantitative PCR, throughout the developmental
cycle. In addition to these studies, we have carefully monitored chlamydial
inclusion formation by confocal microscopy and transmission electron
microscopy. A new  /chlamydial shuttle vector (pNigg::GFP) wasE.coli
constructed using standard cloning technology and used to transform C.
 for further phenotypic studies.muridarum
 We have advanced the definition of the chlamydial phenotype awayResults:
from the simple static observation of mature inclusions and redefined the C.
 plasmid-based phenotype on growth profile and inclusionmuridarum
morphology. Our observations on the growth properties of plasmid-cured C.
 challenge the established interpretations, especially with regard tomuridarum
inclusion growth kinetics. Introduction of the shuttle plasmid pNigg::GFP into
plasmid-cured   restored the wild-type plasmid-bearing phenotypeC. muridarum
and confirmed that loss of the plasmid was the sole cause for the changes in
growth and chromosomal replication.
 Accurate growth curves and sampling at multiple time pointsConclusions:
throughout the developmental cycle is necessary to define plasmid
phenotypes.  There are subtle but important (previously unnoticed) differences
in the overall growth profile of plasmid-bearing and plasmid-free  . C. muridarum
We have proven that the differences described are solely due to the plasmid
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Introduction
Chlamydia muridarum is an obligate intracellular bacterial path-
ogen. It is used to model the pathogenesis of chlamydial infec-
tions in mice1. C. muridarum has a genome comprising a single 
circular chromosome (~1Mb) and a relatively small plasmid of 
7.5 kb2. Chlamydiae have a unique bi-phasic developmental cycle 
alternating between the infectious, extracellular, elementary body 
(EB) and the replicating, non-infectious intracellular form, the 
reticulate body (RB)3. RBs divide by binary fission within an 
intracytoplasmic structure known as an ‘inclusion’4.
Recent discoveries in chlamydial genetics have brought sig-
nificant advances in the field5 and the biology of the chlamydial 
plasmid is being unravelled6. C. muridarum was the first 
chlamydial species that was cured of its plasmid artificially7. 
Inclusions formed by plasmid-free C. muridarum display a 
distinctive morphological phenotype in vitro. This phenotype is 
most evident in near-mature inclusions which, when viewed by 
phase contrast microscopy, appear to have a translucent centre, 
the “bull’s eye” inclusion7. In addition, unlike plasmid-bearing 
isolates, inclusions from plasmid-free isolates of C. muridarum 
and C. trachomatis do not stain with iodine, thus they are 
thought to be unable to accumulate glycogen7–9. Plasmid-free 
Chlamydia strains are important tools because research progress 
in chlamydial plasmid genetics is complicated by the presence 
of the endogenous plasmid. In fact the transforming Chlamydia 
/ E.coli plasmid-based shuttle vectors that are derived from 
endogenous plasmids can recombine with the native plasmid10. 
The use of isogenic, plasmid-cured chlamydial isolates as 
recipient hosts alleviates the uncertainty of potential plasmid/ 
vector recombination. Since the chlamydial plasmid is not essen-
tial for survival, subsequent in vitro genetic studies, mainly in 
C. trachomatis, have indicated the role of plasmid-encoded 
factors in chlamydial biology by analysing the effects of single 
plasmid gene deletions on chlamydial replication and/or inclusion 
morphology11–15. This simple approach has been fruitful in some 
respects but also suffers from severe limitations, e.g. unknown 
polar effects (transcriptional effects of deletions on adjacent 
genes), unwitting deletion of noncoding small RNAs and off- 
target changes leading to potential misinterpretation of the 
properties of individual genes and/or their products. Regardless, 
C. trachomatis and C. muridarum ‘mutants’ carrying specific 
plasmid gene deletions have been used in a large number of such 
studies of chlamydial pathogenicity, as reviewed by Zhong16.
In previous studies of C. trachomatis, we noted that naturally 
occurring, plasmid-free isolates displayed altered growth cycles, 
with longer lag phases and lower yields than their partners 
bearing recombinant shuttle plasmids17. It seems paradoxical that 
those strains of C. trachomatis bearing plasmids have shorter 
developmental cycles despite carrying a significantly increased 
metabolic/genetic burden due to the replication of multicopy 
plasmids and/or larger shuttle vector plasmids. By contrast, all 
published studies performed with C. muridarum indicated that 
plasmid-free strains had similar growth properties (i.e. inclusion 
formation and replication kinetics) as the wild-type, plasmid- 
bearing host7,18,19. Whilst characterising the growth characteristics 
of C. muridarum, we noticed that these descriptions of 
C. muridarum are in conflict with our observations. This is, we 
believe, of critical importance since growth kinetics are a central 
characteristic of the chlamydial phenotype and both reflect 
complex intracellular interactions and influence many aspects 
of experimental design, including studies on pathogenicity. In 
this study, our aim was to accurately compare and contrast the 
C. muridarum plasmid-free phenotype with that of a chromo-
somally isogenic plasmid-bearing strain, over time, by recording 
several parameters. We measured infectivity and chromosomal 
replication by quantitative PCR under strictly controlled condi-
tions. In parallel to these quantitative studies, we have carefully 
monitored inclusion formation by confocal microscopy and 
transmission electron microscopy. By combining these obser-
vations, we have advanced the definition of the chlamydial 
phenotype away from the simple static observation of mature 
inclusions and have set out to define a plasmid-carrying 
phenotype based on growth kinetics and on inclusion morphology 
as it changes with time during the development cycle.
Methods
Chlamydia infection and cell culture
There are several distinct strains of C. muridarum, which display 
a range of phenotypic and virulence diversity20. We have selected 
the strain Nigg Atherton II, for which there is a defined 
genome sequence and which was initially plaque purified by 
Dr. Kyle Ramsey in Chicago. This strain very likely has the 
same origin as the ‘Nigg’ strains used by others in C. muridarum 
plasmid curing and subsequent genetic experiments although the 
full passage history is not entirely clear in these publications7,13.
C. muridarum strain Nigg Atherton II was provided by 
Prof. R. Rank to Prof. Kyle Ramsey and originally obtained from 
Prof. A. Barron1. This isolate was previously known as the causa-
tive agent of mouse pneumonitis. It was plaque-purified three 
times to ensure clonality. The clonal, plasmid-bearing strain is 
specifically referred herein as C. muridarum P+. It was grown in 
McCoy cells (NCTC, Public Health England, UK) in DMEM sup-
plemented with 10% foetal calf serum containing cycloheximide 
at 1μg/ml12. EBs were centrifuged onto cells at 754g (Beckman 
Coulter Allegra X-15R centrifuge) for 30 minutes at room tem-
perature in various formats that included T25 tissue culture flasks, 
96 well trays for qPCR and 12 well trays for infectivity assays. 
The infected cells were then overlaid with culture medium 
containing cycloheximide (1μg/ml) and gentamicin (20μg/ml) 
and incubated at 37°C in 5% CO2. This strain was cured of its 
plasmid using novobiocin as described previously21. The result-
ing plasmid-free isolate C. muridarum, designated C. muridarum 
P- was also subject to three rounds of plaque purification and 
the absence of the plasmid verified by PCR and whole genome 
sequencing.
Stocks of C. muridarum P+ and P- were prepared as described 
previously21 and titres were determined as described in the 
growth kinetics and infectivity assay sections. C. muridarum and 
McCoy cells were routinely tested for mycoplasma contamination 
by fluorescence microscopy and using the Lookout Mycoplasma 
PCR detection kit (Sigma, UK).
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Transmission electron microscopy
McCoy cell monolayers in 25cm2 culture flasks were infected 
with plasmid-bearing and plasmid-free strains of C. muridarum 
at an MOI =3.0, this high ratio was only used for the TEM 
studies to maximise the chances of cutting through the centre 
of an inclusion with the diamond knife. Cell infection was as 
described above. At 28 hours post-infection cells were trypsinised, 
pelleted by centrifugation at 150g for 5 minutes and then 
resuspended in fixative (4% formaldehyde/3% glutaraldehyde in 
0.1M PIPES buffer pH 7.2) for at least 1 hour. Cells were then 
centrifuged at 7,800g for 5 minutes (Fisher accuSpin Micro 
17 centrifuge) into a drop of 5% sodium alginate and then added 
to an equal volume of 0.1M calcium chloride and left to set for 
30 minutes. Embedded cell pellets were then prepared for TEM. 
Pellets were washed with 0.1M PIPES buffer at pH 7.2 and 
post-fixed in 1% osmium tetroxide in 0.1M PIPES buffer at 
pH 7.2 for 1 hour. Pellets were washed again and then en bloc 
stained with 2% aqueous uranyl acetate for 20 minutes before 
dehydrating in increasing concentrations of ethanol. Acetonitrile 
was added and incubated for 10 minutes and the pellet then left 
in 50:50 acetonitrile:Spurr’s resin overnight. Spurr’s resin (100%) 
was added for 6 hours and then the pellet was embedded in fresh 
Spurr’s resin, which was allowed to polymerise at 60°C for 
24 hours. Thin sections (60 to 90nm gold) were cut and stained 
on the grid with Reynolds’ lead citrate. Negatively stained and 
thin-section grids were examined in a Hitachi H7000 transmission 
electron microscope.
Confocal microscopy
McCoy cells seeded onto glass coverslips in 12 well trays were 
infected with C. muridarum P+ and plasmid-free C.muridarum 
P- at an MOI=1.0 as described above, and then fixed at 
4-hour time intervals between 0 and 40 hours post-infection 
using 4% paraformaldehyde for 15 minutes. Cells were washed 
in PBS and permeabilised in saponin buffer (0.1% saponin, 10% 
foetal calf serum, 0.1% sodium azide) for 1 hour at 4°C. Primary 
and secondary antibodies were added to the coverslips, and 
incubated in saponin buffer for 1 hour at room temperature; 
the coverslips were washed in saponin buffer between steps. 
A mouse monoclonal primary antibody raised against genus-
specific LPS (Chlamydia Biobank Cat. No. #CT601 RRID: 
AB2721933) was diluted 1:1,000 and combined with an anti- 
mouse-Alexa Fluor® 488 conjugate secondary antibody (Inv-
itrogen™ Cat. No. A11001 RRID AB_2534069) (1:200 
dilution) to visualize C. muridarum. Cells were counterstained 
with 1 μg/ml DAPI (Fisher Scientific) and Wheat Germ Aggluti-
nin Alexa Fluor® 594 conjugate (Invitrogen™ Cat. No W11262)), 
washed a final time in PBS and mounted onto slides with 
Mowiol 4-88 (Sigma). Images were captured using a Leica TCP 
SP5 confocal microscope.
Growth kinetics and infectivity assay using X-gal staining
McCoy cells grown to confluence in 12 well trays were infected 
with C. muridarum P+ and P- at an MOI=1.0 as described above 
and then harvested at 4 hour time points between 0 and 36 hours 
post-infection. At each time point, cells were detached from the 
well through scraping with a sterile 1ml tip, glass beads were 
added before agitation for 1 min to release the elementary bodies 
from the cells. The suspension was added to an equal volume of 
4 x Sucrose Phosphate (4SP) and stored at -70°C. To assess 
infectivity at each time point, C. muridarum was titrated in 
10-fold dilutions on a 96 well tray and fixed at 28 hours post- 
infection using 100% methanol for 20 minutes at -20°C. Full 
details of the infectivity assay are described in Skilton et al.22. 
Briefly, a mouse monoclonal primary antibody raised against 
genus-specific LPS (Mab29) was incubated with the infected 
cells overnight at 4°C. The cells were then washed with PBS and 
incubated with an anti-mouse antibody conjugated with 
β-galactosidase (Millipore Cat.No. 401607-1ML, RRID:AB_
10684675) for 1 hour at 37°C. For staining, 100μl of a stain-
ing solution [5.0mM K3Fe(CN)6, 5.0mM K4Fe(CN)6·3H2O, 
2.0mM MgCl2·6H2O, 0.25M 5-bromo-4-chloro-3-indolyl-β-d-
galactopyranoside (X-Gal)] was added per well and incubated for 
4 hours at 37°C. The chromogenic X-Gal substrate generated 
blue-stained C. muridarum inclusions, which were then counted 
and titres were calculated.
Time course of infection for qPCR analysis
McCoy cells grown to confluence in 96 well trays were infected 
with C. muridarum P+ and P- at MOI = 1.0 as described above. 
For each time point, cells were infected in quadruplicate, and 
the infection was stopped at 0, 4, 8, 12, 16, 20, 24, 28, 32, and 
36 hours post-infection. At each time point, a tray was stored at 
-70°C for subsequent nucleic acid extraction.
Chromosome quantification by real-time quantitative PCR
The quantification of chromosomal DNA at each time point 
was accurately determined by performing 5′-exonuclease (Taq-
Man) assays with unlabelled primers and carboxyfluorescein/
carboxytetramethylrhodamine (FAM/TAMRA) dual-labelled 
probes. A pan chlamydial PCR assay was developed, prim-
ers and probe sequences were as follows,: CM_omcB_F 
(5’-GGAGATCCTATGAACAAACTCATC-3’), CM_omcB_R 
(5’-TTTCGCTTTGGTGTCAGCTA-3’), CM_omcB_Probe 
(5’-FAM-CGCCACACTAGTCACCGCGAA-TAMRA-3’). Five 
microliters of each sample was added to 20μl reaction mixture con-
taining forward primer (400nM), reverse primer (400nM), probe 
(200nM) and SensiFAST Probe Lo-ROX mix (Bioline). Real-time 
PCR cycles (95°C for 5 minutes, followed by 40 cycles of 95°C 
for 10 seconds and 60°C for 50 seconds) were performed in 
a 7500 Fast Real-Time PCR System (Applied Biosystems).
A standard curve was prepared using plasmid DNA prepared 
in E.coli (pSRP1A) containing the omcB gene from C. tracho-
matis L1, which has identical priming sites in the C. muridarum 
chromosome23.
Chromosome and plasmid sequencing
Sequencing of the C. muridarum P- chromosome was performed 
using Illumina MiSeq at the Sanger Centre, Cambridge, UK, 
with multiplexing using paired read lengths of between 75 bp and 
100 bp, giving a depth of coverage of 5x for the plasmid-free 
genome. The raw sequence data can be accessed from the 
European Nucleotide Archive, accession number ERS351386. 
De novo genome assembly of the resulting reads was performed 
using Velvet (version 1.2.09) for short paired reads, with a 
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chosen K-mer length of 73. The final results gave 23 nodes and 
an N50 of 1,051,043. The assembly was ordered against reference 
genome NC_002620 (which includes the plasmid sequence) 
using ABACAS (version 1.3.2) (Algorithm Based Automatic 
Contiguation of Assembled Sequences; SourceForge). No plasmid 
sequence reads were found. The annotation of reference sequence 
NC_002620 was then transferred to the C. muridarum P- 
assembly. Genes TC_0412 and TC_0236 were identified and 
checked for the SNPs previously suggested as being involved in 
restoration of infectivity in plasmid-free isolates24,25.
Plasmid pGFP::Nigg was constructed from pSW2NiggCDS221, 
which has a unique Spe I site within CDS2 (from pNigg) and 
a unique Mlu I site in CDS 1 (from pSW2). The SpeI-MluI 
fragment in pSW2NiggCDS2 (including CDSs 3-8 from pSW2) 
was replaced with the SpeI-MluI fragment by PCR using 
primers CDS2_F(SpeI): 5’- TCCAGAACTAGTTACGAAGACCA 
AAC -3’ and CDS1_R(Mlu I): 5’-AAAAAAACGCGTCTCCA 
AAAGTTAGGAATAGCCTACTTCT -3’, and total genomic 
DNA of C. muridarum P+ (containg pNigg) as the template. The 
resulting plasmid contained the entire pNigg CDS2-8 and also 
48nt of pNigg CDS1 (from the start codon) which was in-frame 
and fused with truncated pSW CDS1 at the Mlu1 site. Plasmid 
pGFP::Nigg DNA was sequenced verified using the complete 
plasmid sequencing service using Next-Generation sequencing 
technology at Massachusetts General Hospital CCIB DNA Core, 
Cambridge MA, USA. The complete sequence of pGFP::Nigg 
is available as a FastA file (Supplementary File 1).
Statistical analysis
One step growth curves and chromosomal replication graphs 
were produced in GraphPad Prism (GraphPad Software, USA, 
version 7.0.3.0), inclusion size measurement from confocal 
images was executed in ImageJ (NIH, USA, version 1.8.0_112) 
and all remaining statistical calculations were performed in 
Excel (Microsoft, USA, version 15.0.4989.1000). All values are 
expressed as means ± standard deviation (SD) of two to four 
replicates. Comparisons of means were performed by using a 
two-tailed Student t-test for independent samples. The single or 
multiple inference significance level was set to 5%.
Results and discussion
Plasmid curing and genomic sequence of the resultant  
C. muridarum P- strain
The plasmid-bearing wild-type C. muridarum P+ strain was 
cured of its endogenous plasmid using novobiocin21. To ensure 
purity and experimental rigour, this plasmid-cured isolate was 
plaque purified three times (using cycloheximide in the media) 
and designated C. muridarum P-. During this process, we did not 
observe significant differences in the sizes of plaques produced 
by plasmid-cured clones of C. muridarum P- in McCoy cells 
compared to the wild-type isolate. Both formed plaques of 
similar size; plaque characteristics of both the parental strain 
C. muridarum P+ and its plasmid-free derivative strain, C. muri-
darum P-, at six days post infection are shown in Figure S1.
Supplementary file 2
Comparison of plaque assay protocols has revealed differences 
in plaque sizes and morphology, dependent on the method used26. 
All experiments described in this study were performed using a 
standard protocol using cylcoheximide in the culture medium. 
It is noteworthy that whilst C. muridarum can efficiently infect 
cells without the need for centrifugation, we have incorporated 
this step to ensure reproducibility of conditions. The use of 
cycloheximide removes variable and uncontrollable inter- 
experimental host effects (e.g. cell division) by blocking host 
translation. Plaquing using our simple, standard agarose over-
lay protocol takes place over extended periods of time and up to 
six days. Plasmid-cured C. muridarum have been described with 
either small plaque phenotypes7,19 or normal plaques18,25. Many 
subtle variations are reported in the plaque assay protocols, 
including choice of cells, incubation times and infection process, 
all of which may account for the differences observed in plaque 
sizes and reported by others in C. muridarum. In fact the use of 
cycloheximide has been reported to affect chlamydia cell lysis 
processes27 and this may be a factor explaining why we only found 
C. muridarum with normal plaque phenotypes.
We observed that plaque size was dependent on incubation 
time and plaque morphology was also variable. Whilst plaques 
appeared circular to the naked eye, higher magnification revealed 
variations (Figure S1B) and thus plaque diameter was not a 
constant nor a consistent characteristic. Thus plaque assays were 
used only for ensuring clonality of the strains used in this study. 
Furthermore, since plaque formation was variable and plaques 
often overlapped, our evaluations of infectivity in this study were 
determined through manual count of inclusions stained with 
a chlamydial genus-specific monoclonal antibody (inclusion 
forming units). Furthermore, a plasmid deficient C. muridarum 
has been shown to have reduced infectivity/ plaquing efficiency 
but no difference in its ability to form inclusions18,27. Measuring 
inclusion forming units has proven an enduring, reproducible and 
accurate way of defining the infectivity of viable preparations of 
chlamydia28,29.
De novo assembly of the C. muridarum P- genome sequences 
and ordering of these against the reference genome NC_002620 
showed that the C. muridarum P- sequence was free of any 
plasmid reads as expected, and there were no chromosomal rear-
rangements in comparison to the reference sequence. Mutations 
identified in CM3.1 and CM97224 have been linked to restoration 
of infectivity in plasmid-free isolates. In TC_0412 there was a 
single nucleotide insertion (T) in C. muridarum P-, 14bp upstream 
of that found in CM3.1 and CM972, causing a frame shift 
mutation. However, this same mutation was identified in the 
wildtype parent strain chromosome (GCA_000174975.1), pre-
cluding it from any involvement in the restoration of infectivity in 
plasmid-free strains. The mutation identified in TC_0236 in 
CM3.125 was absent in C. muridarum P-.
The morphological phenotype of inclusions formed by 
C. muridarum P- defined by phase contrast and electron 
microscopy
To pinpoint the formation of the bull’s eye phenomenon, images 
of developing inclusions were taken across a time course by phase 
contrast microscopy to discover when the bull’s eye phenotype 
was most obvious in C. muridarum P- infected McCoy cells. The 
bull’s eye phenotype becomes clearly apparent (~90% inclusions) 
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at 28 hrs post infection while the equivalent inclusion 
morphology of the cognate plasmid bearing strain at this time 
point shows mainly wild – type inclusions.
Mature inclusions of plasmid-cured C. muridarum P- at 28hrs 
post infection displaying the bull’s eye phenotype characteris-
tic of plasmid-free isolates of C. muridarum P- are shown in 
Figure 1. By contrast C. muridarum P+ displayed the standard, 
well-recognised regular mature wild-type inclusion morphol-
ogy characteristic of this host. The time course analyses were 
stopped at 36 hrs post infection when the developmental cycle 
and DNA replication were complete, at this time there were no 
discernible differences in host cell lysis between P+ and P- as 
measured by phase contrast microscopic examination.
The phenotype of normal inclusions of plasmid-bearing 
Chlamydia have been well characterised3. However, detailed 
description of the phenotype of the bull’s eye inclusion from 
naturally occurring plasmid-free or plasmid-cured isolates has 
proven elusive and hence difficult to define. There is only one 
description of a plasmid-free inclusion from C. trachomatis by 
transmission EM30. This description is from a naturally occur-
ring plasmid-free strain and no TEM image of inclusions from 
plasmid-cured isolates have been reported in the literature. 
EM is useful as it allows for the level of resolution required to 
observe individual EBs and RBs. We noted that the bull’s eye 
phenomenon was a transient effect as it was not evident early in 
infection nor was it visible in every inclusion; presumably the 
orientation and size of the inclusions with respect to the light 
path may explain this phenomenon.
To look deeper into the inclusion structure of the plasmid-free 
phenotype in C. muridarum we used TEM to achieve higher 
resolution of the inclusion. To maximise the chances of slicing 
through an inclusion, we used a higher MOI (MOI=3.0), and to 
preserve inclusion structure, the infected cells were mixed with 
alginate prior to fixing and embedding in EM resin.
Figure 1 shows the morphology of mature inclusions from 
C. muridarum P- and its wild type counterpart C. muridarum P+ 
examined by phase contrast microscopy and EM. Profound dif-
ferences are visible between inclusions formed by plasmid–cured 
Figure 1. Phase and electron micrograph images of C. muridarum inclusions. Phase contrast microscope (A & B) and transmission 
electron microscope (C & D) images of C. muridarum P+ (A & C) and P- (B & D) inclusions at 28 hours post infection in McCoy cells. 
‘Bulls-eye’ phenotype of the plasmid-free strain can be seen in panels B & D.
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and wild type C. muridarum in terms of basic morphology 
as revealed by these analyses.
Confocal analysis of the developmental cycle of  
C. muridarum P-
Our initial studies aimed at describing the morphology of 
inclusions formed by C. muridarum P- showed that there were 
differences in the rate of development of inclusions between the 
P + and P- strains. These observations stand in contradiction 
with previous kinetic studies using plasmid-cured C. muridarum, 
which reported no difference between plasmid bearing and 
plasmid-cured strains7,18,19.
Whilst EM is useful to define structures, the extensive fixation 
processes and the limited chances of cutting thin sections through 
the centre of inclusions make this approach to study the morphology 
of inclusion development difficult. Thus to plot precisely the 
changes in inclusion size within a dynamic framework and at 
higher resolution than phase contrast, we investigated the process 
of inclusion formation by confocal microscopy during the devel-
opmental cycle. For consistency and reproducibility, we used the 
same reagents in this analysis as in later infectivity assays. Thus 
we used the monoclonal antibody Mab 29, which is directed at 
chlamydial LPS. Here the fluorescence signal recorded during 
imaging of confocal microscopy masked the bull’s eye appearance 
of the inclusions. Time courses of infection for C. muri-
darum P+ and C. muridarum P- by confocal microscopy of 
inclusions are shown in Figure 2A. Inclusion areas were meas-
ured using the open platform scientific analysis software Image J 
version 1.8.0_112.
Our images showed conclusively that inclusion size in P- is 
significantly smaller than in P+ at the same time points up to 
28hrs post infection in the developmental cycle. This demon-
strates that the phenotype of a plasmid-free strains should be 
considered not just at a single time point at or near the end of 
Figure 2. C. muridarum developmental cycle visualised by confocal microscopy. Confocal microscope images (A) of C. muridarum 
P+ and P- infected McCoy cells at set time intervals in the developmental cycle and quantification of the inclusion sizes seen (B). Mouse 
monoclonal primary antibody raised against genus-specific LPS (Mab29) detected with anti-mouse Alexa Fluor® 488 conjugate secondary 
antibody staining inclusions green. Cells were counter-stained using wheat germ agglutinin Alexa Fluor® 594 staining the plasma membrane 
(red) and DAPI to identify the cell nucleus (blue). Mean and standard deviation of inclusion size, expressed as square pixels, measured from 
the confocal microscope pictures during the course of 1-step growth curve using ImageJ software. *p<0.01, **p<0.00001, #p<0.0001.
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the developmental cycle, but as a series of frames encompassing 
differences in inclusion size and morphology throughout the 
time course of infection. Consistent with overall larger inclu-
sion size at 32 hrs post infection, the maturation of inclusions for 
C. muridarum P- occurs 4hrs later than for C. muridarum 
P+. Whilst detailed morphological time courses of inclusion devel-
opment have not been previously performed on C. muridarum 
P- , the data confirmed that there were clear differences in the 
overall growth profile of P- and P+, with C. muridarum P- 
initially showing smaller inclusions and delayed inclusion 
development. These subtle but critical differences are in stark 
contrast to analyses from previous studies, which concluded 
that the developmental cycle is identical in duration and 
yield for C. muridarum plasmid-bearing and plasmid-cured 
clones7,18,19.
One step growth kinetics
Bacterial fitness reflects the ability of a microorganism to adjust 
its metabolism to suit growth conditions. Measuring growth rates 
under defined culture conditions is an objective way of assess-
ing fitness and deduced generation time is the optimal meas-
ure to compare the fitness of strains. In our experience, both 
chlamydial plaque size and plaque morphology are unreliable 
parameters for characterising differences between chlamydial 
strains. Chlamydial plaque assays of the same strains are vari-
able and dependent on perfectly optimised conditions to obtain 
accurate enumeration of infectivity26. The results also depend 
on the physiological quality of the cells. For consistency we 
always use cycloheximide when culturing Chlamydia. Our 
preferred approach to obtain accurate chlamydial infectivity 
titres was to use an assay using objective quantifiable factors, 
which removes potential observer bias from the measurements. 
Therefore to perform accurate growth kinetic analyses, infec-
tivity was measured by inclusion staining assay. These assays 
were performed in duplicate so that statistically significant data 
could be obtained allowing accurate measures of infectivity. This 
technique avoids the need for plaque formation, only detecting 
a primary infection and is thus highly sensitive and provides 
accurate quantifiable data. Since LPS is essential for chlamy-
dia survival, all inclusions were stained, regardless of size and 
were clearly identifiable by their discrete and distinctive staining 
profile/morphology within the cell cytoplasm22.
One step infectivity growth curves were performed in 24-well 
trays using carefully titred inocula of P+ and P-. To ensure 
species compatibility, murine McCoy cells were used and 
infected at an MOI of 1. Samples were taken for infectivity assay 
at four hourly periods from 8hrs post infection to the end of the 
experiment.
Consistent with the confocal microscopical observations, which 
showed smaller inclusions of the C. muridarum P- in all the 
early stages (up to 28hrs) of the developmental cycle, the growth 
kinetics showed subtle differences in one step infectivity growth 
curves between P+ and C. muridarum P- as seen in Figure 3. 
C. muridarum P- had a 4 hr longer eclipse period and whilst 
its doubling time was not significantly different, the yield of 
infectious progeny was five times lower than its plasmid- 
bearing cognate counterpart P+. This observation is in con-
trast to the reported results comparing developmental cycles of 
plasmid cured C. muridarum in other laboratories using plaque 
assays7,18,19.
Re-examination of the published growth kinetics data for 
plasmid-cured ‘small-plaquing’ strain C. muridarum CM972 
and its larger plaquing derivative CM3.1 indicated that there are 
in fact growth profile differences; despite the original claim by 
the authors18. Even though this study was performed using the 
lower efficiency plaque assay procedure, figures clearly showed 
that plasmid-cured isolates have a 25% longer eclipse phase 
relative to the plasmid bearing parent, thus we believe the 
conclusion that there are no differences between plasmid cured 
and plasmid bearing isolates is incorrect18. The data from the other 
studies where no differences between P + and P- growth 
Figure 3. Comparison of infectivity growth profiles for C. muridarum P+ and P- strains. One step growth curves measured by inclusion 
assay of infectious EBs. Infected McCoy cells were removed for analysis at 4 hourly time intervals and then titrated to assess the quantity of 
inclusion forming units. Inclusions were stained and counted using a mouse monoclonal primary antibody raised against genus-specific LPS 
(Mab29) detected with anti-mouse β-galactosidase conjugate secondary antibody staining inclusions blue in the presence of X-gal. All values 
are expressed as means ± standard deviation (SD) of two replicates.
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profiles are reported did not provide data of sufficient resolution 
to allow a re-evaluation19.
Chromosomal replication was measured by qPCR analysis, 
which gives an accurate numerical measure of the replication of 
the DNA, providing an additional quantifiable objective and pre-
cise measure of the developmental cycle. Because replication 
occurs before infectious EBs are formed, the gradients of the 
qPCR curves were not as pronounced as observed with the infec-
tivity curves, which measured infectious EBs through IFU. 
Nevertheless the qPCR analysis verified both the longer ‘eclipse’ 
period and the reduced yield for C. muridarum P- as shown in 
Figure 4.
The doubling time of C. muridarum P+ and P-, defined as t/χ 
where t is the hours of exponential growth and χ is the number 
of generations, was calculated by analysing the 1-step growth 
curves for infectivity (IFU) as well as chromosome replication. IFU 
measurement showed that during the exponential growth 
phase, (when RBs are dividing and differentiating into infectious 
EBs), C. muridarum P+ and P- had an estimated doubling time 
of 47 and 83 minutes respectively, (16 to 24 h.p.i. for P+ and 
20 to 32 h.p.i. P-), suggesting a longer generation time (although 
this was not statistically significant) for the plasmid-cured 
C. muridarum (see Table S1). By contrast, differences were much 
less noticeable when the entire development cycle was taken into 
account (182 and 205 min for P+ and P-, respectively), falsely 
implying a similar overall growth behaviour in both cases.
Conversely, measurements of C. muridarum P+ and P- chro-
mosome replication provided no evidence of a longer doubling 
time for P- during either the exponential phase (84 and 87 min for 
P+ and P-, respectively) or the whole development cycle (296 and 
237 min for P+ and P-, respectively). This last observation can 
be explained by the fact that DNA replication begins at an earlier 
stage than both RB division and differentiation into EBs; hence, 
this phenomenon smoothens the typical sigmoidal ‘infectivity’ 
growth curve.
Tranformation of C. muridarum P- with pGFP::Nigg
To prove that the loss of the plasmid was the sole cause of the 
change in growth and chromosomal replication profile, it was 
necessary to re-introduce the plasmid into the C. muridarum P-. 
Therefore we constructed a recombinant plasmid pGFP::Nigg 
using a previously described strategy for making recombinant 
shuttle plasmids in C. trachomatis17. The map of the plasmid is 
shown in Figure 5.
The resultant recombinant plasmid was verified by sequence 
analysis, the nucleotide sequence of pGFP::Nigg is presented in 
Supplementary File 1.
Plasmid pGFP::Nigg is a vector constructed specifically for 
C. muridarum transformation. Plasmid pGFP::Nigg is similar 
to the widely used C. trachomatis vector pGFP::SW2; the only 
difference is that the pSW2 CDSs 2-8 in pGFP::SW2 have been 
replaced with pNigg CDSs 2-8.
Since CDS1 is essentially redundant in C. trachomatis31 (and 
other chlamydial species e.g. C. pneumoniae32) we expected that 
insertion of the E.coli shuttle vector within this gene would have 
little or no effect on the properties of the plasmid, as demon-
strated with similar recombinant C. muridarum shuttle plasmids 
constructed by others pBRCM33 and pGFP::CM13 which were also 
cloned via CDS1. C. muridarum P- transformed by pGFP::Nigg 
was selected with penicillin and resulted in the development of 
green inclusions; it was additionally chloramphenicol resistant. 
Transformation of C. muridarum P- with pGFP::Nigg restored 
the wild type inclusion phenotype when grown in McCoy cells 
without antibiotics.
Figure 4. Chromosomal replication during the developmental cycle of C. muridarum P+ and P-. Infected McCoy cells were removed 
for qPCR analysis at 4 hourly time intervals and the relative number of chlamydial genomes were determined using the C. muridarum omcB 
assay. All values are expressed as means ± standard deviation (SD) of four replicates.
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A one step DNA replication assay of C. muridarum P- transformed 
by pGFP::Nigg was performed and compared with chromosomal 
replication one step curves for C. muridarum P- and P+ as shown 
in Figure 6.
Analysis of chromosomal DNA replication of C. muridarum 
P- transformed by pGFP::Nigg showed that the recombinant 
plasmid restored the shorter eclipse period and the replica-
tion profile from 8 to 20hrs post infection was similar to the 
C. muridarum P+, but then chromosomal replication flattened.
These data indicate that the plasmid plays a key role in deter-
mining the overall growth profile because a shorter eclipse phase 
of the growth kinetics is restored.
Conclusions
1. The discovery and definition of subtle phenotypic differences 
between plasmid bearing and plasmid cured isolates is important 
as it could have critical impact on chlamydial growth, affect-
ing experimental design, in vivo research and vaccine develop-
ment. These differences could be species or even strain specific, 
thus caution should be exercised in making generalisations 
about specific plasmid phenotypes.
2. We have tried to replicate work from previous literature on the 
study of C. muridarum and been unable to reproduce specific 
outcomes regarding inclusion development and growth kinet-
ics. Reproducibility is a fundamental scientific principle, thus all 
our experimental data is made available here for others to repeat 
the findings, together with our full protocols, which we hope will 
enable open debate of these critical issues and guide the field 
in the future. Reproducible methods and high quality data are 
essential to ensure that research findings are based on the best 
possible evidence and we conclude that accurate and highly 
reproducible methods should be included in future studies on 
plasmid phenotypes.
Figure 5. Map of the plasmid vector pGFP::Nigg. The inner circle represents the chlamydial plasmid (blue) and the vector sequences (red). 
The coding sequences and their direction of transcription are represented by the boxes of the outer circle. The CDS2-8 were from pNigg in 
C. muridarum Nigg. The cat gene is fused with RSGFP (green) and expressed by a promotor derived from Neisseria meningitides (nmP).
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Figure 6. Graph showing the effect of restoring the plasmid to C. muridarum P- on chromosomal replication. C. muridarum Nigg P- was 
transformed with pGFP::Nigg and used to infect McCoy cells. Samples were removed for qPCR analysis at 4 hourly time intervals and the 
relative number of chlamydial genomes were determined using the C. muridarum omcB assay throughout the developmental cycle.
3. It is now timely and appropriate to advance the definition 
of the Chlamydia plasmid-related phenotypes away from the 
simple notion of the static observation of mature inclusions or 
purified EBs at a single time point. It is necessary to re-define 
plasmid-based phenotypes by careful and accurate analysis and 
comparison of growth kinetics and, where necessary, combine 
these with morphological observations of inclusion structure. 
The sampling of multiple, regular time points covering the whole 
developmental cycle for infectivity, DNA replication and gene 
expression is necessary. The use of single data points and even 
the selective use 3 or 4 time points for sampling is insufficient. 
A rigorous multiple time point sampling approach is necessary 
for investigating specific protein expression/regulation. We 
believe that this level of experimental rigour should be the stand-
ard as part of accurate new protocols for measuring phenotypic 
characteristics of chlamydial mutants.
4. From applying these principles we conclude that the pNigg 
plasmid alone is responsible for the differences observed in 
growth properties observed between C. muridarum P+ and P-.
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Supplementary material
Supplementary File 1. Complete sequence of the plasmid vector pGFP::Nigg.
Click here to access the data.
Figure S1. Plaques of C. muridarum P+ and P-. McCoy cells infected with C. muridarum P+ (A) and C. muridarum P- (B) at the same 
multiplicity of infection were stained with neutral red at 6 days post infection. The assay was performed in 6-well tissue culture trays and 
individual plaques are indicated by arrows. Higher magnification (4X) of neutral red stained plaques are shown. The figure is representative 
of 3 images (see data).
Click here to access the data.
Table S1. Doubling time of C. muridarum P+, P- and P- +pGFP::Nigg during either the exponential phase or the whole development 
cycle. (A) RB replication; (B) Genome replication. All values are expressed as means ± standard deviation (SD) of two/four replicates. 
Comparison of means was performed by using a two-tailed Student’s t-test for independent samples.
Click here to access the data.
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The manuscript by Skilton  . reports the novel finding that a plasmid-negative mutant strain of et al
 is impaired for growth compared to the plasmid-positive parental strain in a cellChlamydia muridarum
culture infection model. These results are in contradiction to previous studies with   plasmidC. muridarum
mutants, but are consistent with reports for   plasmid mutants. Additionally, normalChlamydia trachomatis
growth appears to have been restored through complementation with a newly developed C. muridarum
shuttle vector. Growth was measured throughout the development cycle via IFU production, inclusion
size, and chromosome equivalents. The authors conclude that: 1) plasmid deficient   isC. muridarum
growth impaired, 2) differences in growth can be attributed solely to the presence or absence of the
plasmid, 3) growth should be assessed throughout development rather than using end-point analysis or
plaque assay, and 4) that assessment of growth at multiple time points throughout development is
essential for characterizing mutants and should become standard practice for the chlamydial field for
which genetics has only recently become widely applicable.
This is a well-written and timely manuscript. With the increased use of plasmid-based genetic tools in 
 it is important that the field adopts reproducible and rigorous methods for analyzing mutantsChlamydia
and this seems to be a clear goal of the authors based on their concluding statements. In addition, the
findings from this manuscript, which contradict prior studies, are significant in that the C. muridarum
-mouse infection model is widely used in the community for exploring chlamydial pathogenesis and an
increasing number of studies with mutants are likely on the horizon.
There are a few technical weaknesses that impact what appears to be a broader manuscript theme –
carefully discerning phenotypic differences between mutants through standard methods of analyses –
that if addressed would strengthen the manuscript. The proposed replications of specific experiments
might also further buttress the argument that growth differences in cell culture do exist between
plasmid-positive and plasmid-negative   matched-strains, a finding that differs from priorC. muridarum
studies.
Major Criticisms:
The ability to discern phenotypic differences between a panel of strains, in this case the P+ (parental,
wild-type), P- (plasmid-cured mutant), and P+pGFP (complemented) strains, would seem to hinge on the
use of multiple experimental approaches performed with an appropriate number of biological replicates.
As the authors are presenting data that conflicts with prior reports/interpretations and are seeking to lay
the foundation for how mutants are to be analyzed in the future, this topic seems particularly pertinent to
the experiments reported in this manuscript.
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 the foundation for how mutants are to be analyzed in the future, this topic seems particularly pertinent to
the experiments reported in this manuscript.
1) In figure 1, the “Bulls-eye” inclusion phenotype for the P- mutant is clearly shown in both phase-contrast
and EM images. The authors report that plasmid-complementation of the P- mutant restores the wild-type
inclusion phenotype. Addition of a phase-contrast image of a field of cells infected with the P+pGFP strain
should be included with figure 1. This may require a minor restructuring of the manuscript to include the
complementation and vector information earlier in the results section. However, this rearrangement is also
suggested for addressing the remaining major criticisms.
2) The inclusion size data shown in figure 2, representing one of the three quantitative approaches used
to support differing phenotypes amongst the strains (along with IFU production and genome equivalents),
is an essential part of the results. The data show a significant difference in inclusion size at early time
points and document a growth defect that would be missed if assessed only at the end stage. However,
based on the data provided through the OSF server, the data seem to be derived from a single biological
replicate, the 12-hour time point data is derived from only 2 (P+) and 3 (P-) inclusions, and the average
number of inclusions measured per time point (excluding the 12 hr) is only 14. The 12-hour time point
data might have been limited due to the small size of the inclusions. However, the overall inclusion counts
are low, and it is suggested that an additional biological replicate is performed to increase inclusion
counts and ensure reproducibility. In addition, inclusion of the P+pGFP strain in the data set would
strengthen the claim that all phenotypic differences are due to the plasmid by providing an extra
quantitative measurement of the fitness of the complemented strain.
3) In figure 3, it is not clear why the 32-hour time point was selected for calculating the growth rate of the
P- mutant (“20 to 32 h.p.i.”). The 28-hr time point would seem to better reflect the time at which the strain
exits from the exponential growth phase.
4) Figure 3 - Infectivity growth curve data and growth rate calculations should be included for the
complemented strain.
5) It is recommended to merge figures 4 and 6 reporting the genome equivalents for the P+/P- strains
(figure 4) and P+/P-/P+pGFP (figure 6) into one figure. The gDNA data for these strains also appears to
come from a single experiment that did include four technical replicates. As establishment of reproducible
and robust methods for phenotyping mutants appears to be a major focus of the manuscript, a second
repetition seems appropriate.
Minor Criticisms:
1) The authors state using anti-LPS antibodies.   technically have lipooligosaccharides (LOS)Chlamydia
(PMID 21628561 and 10358025). 
2) Server data – The Infectivity data table lists a 22 hr time point, which is likely the 20 hr time point data.
3) While the time points used to determine the growth rate via genome equivalents can be figured out
using the server data, it would be easier for the reader if they were listed in the text. P+ 8 to 16, P- 12 to
20, and P+pGFP 12 to 24
4) The authors present several valid criticisms of the plaque assay when used as a measurement of strain
phenotypes. However, I would argue that the plaque assay is still a useful method for assessing the
growth phenotype of strains and mutants under a condition that measures growth and infectivity over
multiple developmental cycles. This is reflective of what would happen in an animal, albeit in a much more
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 multiple developmental cycles. This is reflective of what would happen in an animal, albeit in a much more
permissive environment. I do think it is crucial that the parameters used for the plaque assay are explicitly
stated and critical that, when feasible, matching strain sets (parent, mutant, complement) are used for
plaque assay phenotyping in combination with alternative approaches such as those used in this
manuscript.
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Partly
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 23 March 2018Referee Report
doi:10.21956/wellcomeopenres.15117.r31735
  ,    ,    ,    ,    , Ming Tan Julie Brothwell Derifa Kadouche Syed Rizvi Christopher Rosario Qiang
   Zhang
 Departments of Microbiology & Molecular Genetics, and Medicine, University of California, Irvine, Irvine,
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This article nicely analysed growth defects in the intracellular   infection due to absence of theChlamydia
chlamydial plasmid. Skilton and colleagues used growth assays that quantified inclusion area, chlamydial
genome copy number and infectious progeny to show that a   strain cured of its plasmid hadC. muridarum
reduced growth compared to its parental strain (normalization to the number of host cells would have
improved the accuracy of strain comparisons). By measuring growth at multiple timepoints in the
intracellular infection, they demonstrated that the magnitude of the growth defect varied by timepoint. For
example the plasmidless strain produced 2- to 10-fold fewer progeny depending on the timepoint when
EBs were harvested (for this and other assays, it would have been helpful to have a supplementary table
with the numbers, which could only be estimated from the graphs). This variation by timepoint is not too
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2
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 with the numbers, which could only be estimated from the graphs). This variation by timepoint is not too
surprising because of the dynamic nature of the chlamydial developmental cycle – the two strains are
each running their own race – but is new and informative because almost all other published studies have
used a single timepoint to measure chlamydial growth defects. The growth defects of the plasmid-cured
strain stand in contrast to a study by O’Connell and Darville , which reported no growth difference
between plasmid-cured and plasmid-bearing   strains. The reason for this discrepancy isC. muridarum
unresolved.
 
What is the utility of this more detailed timepoint analysis? There are hints that the plasmidless strain has
a delayed developmental cycle but the article refrained from this level of interpretation. There would be an
important difference, particularly with regards to the underlying mechanism, if the growth deficit was due
to a reduction or to a delay, or some combination. Inclusion size was smaller with the plasmidless strain
but eventually caught up (it would have been good to report the number of inclusions too). However
chlamydial genome copies and progeny appeared to show a 4-8 hour delay. Left unmeasured was
whether either growth parameter eventually reached the same level as the plasmid-bearing strain. For
starters it would be useful to know whether lysis of the plasmidless strain occurred later, which would
justify measurements at additional later timepoints.
 
The authors’ one step growth curve for infectious progeny is useful for understanding many other studies
that have attributed chlamydial growth alterations to chlamydial mutations, inhibitors or depletion of
specific host proteins. As in this case, a 5- to 10-fold decrease at a single timepoint is more than likely to
be real. However, this study shows that a smaller reduction in the 2-fold range from a single timepoint
should be considered with some skepticism because it may not be representative of the overall
intracellular infection. In addition, a 2-fold difference is in the range of experimental variation (were the
error bars for later time points in Fig. 3 really that small between the two replicates?). Measurements at
multiple timepoints would then help to determine the overall magnitude of the chlamydial growth defect
and whether it is transient and disappears at later timepoints.
 
Overall the study was well performed and will make the   research community aware of theChlamydia
limitations of measuring growth defects at a single timepoint in the infection. The authors make a
compelling case for a role of the plasmid in chlamydial growth because the plasmidless strain produced a
large growth defect and contained no other sequence alterations compared to the parental strain.
Furthermore there was convincing complementation data showing that reintroduction of the plasmid
restored chlamydial genome copy number. This study did not address the mechanism by which the
plasmid affects growth, but it is known that a plasmid gene pgp4 encodes a transcriptional regulator of
plasmid and chromosomal virulence factors. The conclusions of this article were limited. For example, the
bull’s eye inclusion phenotype and the growth deficit were described and measured but there was little
explanation or speculation of their causes.
References
1. O'Connell CM, Ingalls RR, Andrews CW, Scurlock AM, Darville T: Plasmid-deficient Chlamydia
muridarum fail to induce immune pathology and protect against oviduct disease. . 2007; J Immunol 179
(6): 4027-34 PubMed Abstract
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
1
Page 16 of 18
Wellcome Open Research 2018, 3:25 Last updated: 26 MAR 2018
 Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard.
 23 March 2018Referee Report
doi:10.21956/wellcomeopenres.15117.r31733
 Ted Hackstadt
Host-parasite Interactions Section, Laboratory of Intracellular Parasites, National Institute of Allergy and
Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT, USA
Chlamydia are obligate intracellular pathogens that have only recently become amenable to genetic
manipulation.  Despite the breakthroughs in recombinant DNA technologies, chlamydiae can be difficult
due to their obligate intracellular nature and host specificity, which limits the utility of animal model
systems in the study of the human pathogen,  .  Skilton  have initiated studies of theC. trachomatis et al 
murine pathogen   to examine the role of the endogenous plasmid in pathogenesis.  HereC. muridarum
they present a very basic but thorough characterization of plasmid-bearing and plasmid-free C.
 in cell culture.  Plaque phenotype, rates of progeny formation, and genome equivalents allmuridarum
differ in the plasmid-free strain and the wild type phenotype is restored upon complementation with a
newly described shuttle plasmid.  This background information is useful and the shuttle vector system for 
 will be valuable for studies of a murine chlamydia strain in mouse models.C. muridarum
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